【摘要】 目的探讨核素骨显像在恶性淋巴瘤骨浸润中的临床应用价值。方法收集经病理证实的71例恶性淋巴瘤骨显像患者病例,其中霍奇金淋巴瘤(HL)8例,非霍奇金淋巴瘤(NHL)63例。经静脉注射99mTc-垭甲基二膦酸盐(99mTc-MDP)555-925 MBq后2．5-6h行全身骨显像检查。结果骨浸润病变者31例,其中8例HL中骨浸润3例,63例NHL中骨浸润28例。总病灶数103个,除2个骨放射性缺损外,101个浓聚灶分别为:脊柱35个(34．65％)、四肢骨及关节30个(29．70％)、肋骨14个(13．86％)、骨盆13个(12．87％)、颅骨5个(4．95％)及胸骨4个(3．96％)。结论核素骨显像在恶性淋巴瘤骨浸润的临床分期、治疗监测和预后转归等方面具有较高的临床价值。更多还原

【Abstract】 Objective To evaluate the clinical application value of nuclide bone imaging in malignant lymphoma. Methods 71 cases of patients were diagnosed by pathology as malignant lymphoma, among whom there were 8 cases of Hodgkin disease(HL) and 63 cases of non-Hodgkin disease (NHL). The examinations were performed from 2.5 to 6 hours later after the intravenous injection of 99mTc-MDP (555 ~ 925MBq). Results 31 cases were bone-infiltrating lesions, including 3 cases of HL and 28 cases of NHL. The total number of the focus was 103, except 2 cases of bone lack , including 35 foci in vertebral column (34.65%), 30 foci in limb and joint (29.70%), 14 foci in rib (13.86%), 13 foci in elvis (12.9%), 5 foci in skull (4.95%) and 4 foci in sternum (3.96%). Conclusion The nuclide bone imaging has a high value in the clinical stage, therapeutic observation and prognosis of bone-infiltrating malignant lymphoma.更多还原